You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Online First: June 13, 2011 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Review Article
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Medical Practice
 •Medical Practice, Other
 •Treatment Adherence
 •Quality of Care
 •Evidence-Based Medicine
 •Patient Safety/ Medical Error
 •Quality of Care, Other
 •Statistics and Research Methods
 •Review
 •Less Is More
 •Drug Therapy
 •Adherence
 •Adverse Effects
 •Medication Error
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

ONLINE FIRST
Principles of Conservative Prescribing

Gordon D. Schiff, MD; William L. Galanter, MD, PhD; Jay Duhig, MA; Amy E. Lodolce, PharmD, BCPS; Michael J. Koronkowski, PharmD; Bruce L. Lambert, PhD

Arch Intern Med. Published online June 13, 2011. doi:10.1001/archinternmed.2011.256

Judicious prescribing is a prerequisite for safe and appropriate medication use. Based on evidence and lessons from recent studies demonstrating problems with widely prescribed medications, we offer a series of principles as a prescription for more cautious and conservative prescribing. These principles urge clinicians to (1) think beyond drugs (consider nondrug therapy, treatable underlying causes, and prevention); (2) practice more strategic prescribing (defer nonurgent drug treatment; avoid unwarranted drug switching; be circumspect about unproven drug uses; and start treatment with only 1 new drug at a time); (3) maintain heightened vigilance regarding adverse effects (suspect drug reactions; be aware of withdrawal syndromes; and educate patients to anticipate reactions); (4) exercise caution and skepticism regarding new drugs (seek out unbiased information; wait until drugs have sufficient time on the market; be skeptical about surrogate rather than true clinical outcomes; avoid stretching indications; avoid seduction by elegant molecular pharmacology; beware of selective drug trial reporting); (5) work with patients for a shared agenda (do not automatically accede to drug requests; consider nonadherence before adding drugs to regimen; avoid restarting previously unsuccessful drug treatment; discontinue treatment with unneeded medications; and respect patients' reservations about drugs); and (6) consider long-term, broader impacts (weigh long-term outcomes, and recognize that improved systems may outweigh marginal benefits of new drugs).


Author Affiliations: Center for Patient Safety Research and Practice, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Schiff); Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago (Dr Galanter); and Departments of Pharmacy Administration (Mr Duhig and Dr Lambert) and Pharmacy Practice (Drs Lodolce and Koronkowski), Uiversity of Illinois at Chicago College of Pharmacy, Chicago.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Communicating Uncertainties About Prescription Drugs to the Public: A National Randomized Trial
Lisa M. Schwartz and Steven Woloshin
Arch Intern Med. 2011;171(16):1463-1468.
ABSTRACT | FULL TEXT  

Conservative Use of Prescription Drugs: Comment on "Communicating Uncertainties About Prescription Drugs to the Public"
Deborah Grady
Arch Intern Med. 2011;171(16):1470.
EXTRACT | FULL TEXT  

Opioids for Chronic Pain
Deborah Grady, Seth A. Berkowitz, and Mitchell H. Katz
Arch Intern Med. 2011;171(16):1426-1427.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anti-antibiotics
Wlodaver and May
Arch Intern Med 2012;172:293-294.
FULL TEXT  

Experience Is a Gloomy Lantern That Does Not Even Illuminate Its Bearer
Braillon
Arch Intern Med 2012;172:294-294.
FULL TEXT  

Conservative Prescribing and the Importance of Psychotherapy--Reply
Schiff et al.
Arch Intern Med 2012;172:295-295.
FULL TEXT  

Conservative Prescribing and the Importance of Psychotherapy
Auchincloss et al.
Arch Intern Med 2012;172:294-294.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2011 American Medical Association. All Rights Reserved.